Pharmaniaga plans to raise up to RM655mil

The company’s proposed regularisation plan entails capital reduction, rights issue with warrants and private placement.

PETALING JAYA: Pharmaniaga Bhd plans to raise up to RM655mil to bolster its financial position and exit its Practice Note 17 (PN17) status.

The company’s proposed regularisation plan entailed the proposed capital reduction, rights issue with warrants and private placement.

In a filing with Bursa Malaysia, the cash-strapped company has proposed a capital reduction of the issued share capital of the company by the cancellation of RM180mil issued share capital.

The proposed renounceable rights issue is of up to 1.18 billion new ordinary shares in Pharmaniaga on the basis of four rights shares for every five shares held, together with up to 1.18 billion free detachable warrants on the basis of one warrant for every rights share subscribed.

The proposed private placement is of up to 714.3 million new shares representing up to 26.9% of the enlarged issued share capital of Pharmaniaga after the proposed rights issue with warrants.

“The substantial shareholder of Pharmaniaga, Lembaga Tabung Angkatan Tentera has committed to subscribing up to RM190mil for the rights issuance,” the company stated in a statement.

It added the group has decided to take a prudent step to incur total impairment of RM167mil in the third quarter (3Q23) of which RM121mil involved prior year adjustments.

For 3Q23, Pharmaniaga’s net loss widened to RM49.3mil compared with RM13.9mil achieved in the same period last year. Revenue for the quarter was lower at RM885.5mil against RM894.9mil while loss per share stood at 3.67 sen from 1.07 sen previously.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Japan's Nikkei hits record high as Nvidia lifts Asian tech
Trade, investment targets in 2024 achievable - Tengku Zafrul
Thai PM to keep pressing for rate cut, seeks chief meeting
CIMB Niaga reports record-high PBT of 8.4 trillion rupiah in FY23
E&O's net profit rises to RM34.44mil in 3Q
Sime Darby Plantation optimistic over satisfactory performance in FY24
Axiata records revenue growth from continuing ops in FY23
Maxis posts service revenue, Ebitda growth in FY23
FBM KLCI down amid gobal tech rally
Japan's Nikkei hits record high after Nvidia beat, rest of Asia muted

Others Also Read